FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc Laburthe

Research Profile

Chemicals & Drugs

Concepts & Ideas

Anatomy

Genes & Molecular Sequences

Amino Acid Sequences

Living Beings

Physiology

Disorders

Colonic Neoplasms

Co-author Network

Publications

TOP 3
Alain Couvineau; Emilie Ceraudo; Yossan-Var Tan; Marc Laburthe
Strategies for studying the ligand binding site of GPCRs: photoaffinity labeling of the VPAC1 receptor, a prototype of class B GPCRs.
Emilie Ceraudo; Régine Hierso; Nadège Jamin; Marc Laburthe; Samuel Murail; Jean-Michel Neumann; Pascal Nicole; Patrick Robberecht; Jean-Claude Robert; Christiane Rouyer-Fessard; Yossan-Var Tan; Alain Couvineau
Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
Anthony J Harmar; Marc Laburthe; Victor May; Joseph R Pisegna; Jan Fahrenkrug; Illana Gozes; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc Laburthe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alain Couvineau; Emilie Ceraudo; Yossan-Var Tan; Marc Laburthe
Strategies for studying the ligand binding site of GPCRs: photoaffinity labeling of the VPAC1 receptor, a prototype of class B GPCRs.
Methods in enzymology 2013;520():219-37.
2012: Emilie Ceraudo; Régine Hierso; Nadège Jamin; Marc Laburthe; Samuel Murail; Jean-Michel Neumann; Pascal Nicole; Patrick Robberecht; Jean-Claude Robert; Christiane Rouyer-Fessard; Yossan-Var Tan; Alain Couvineau
Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(5):2060-71.
2012: Anthony J Harmar; Marc Laburthe; Victor May; Joseph R Pisegna; Jan Fahrenkrug; Illana Gozes; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.
British journal of pharmacology 2012;166(1):4-17.
2012: Alain Couvineau; Marc Laburthe
VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins.
British journal of pharmacology 2012;166(1):42-50.
2012: Marc Laburthe
[How to turn a silent proapoptotic gene in a potent antitumoral target in colorectal cancer].
Médecine sciences : M/S 2012;28(3):272-3.
2012: Marc Laburthe; Thierry Voisin
The orexin receptor OX(1)R in colon cancer: a promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs.
British journal of pharmacology 2012;165(6):1678-87.
2012: Alain Couvineau; Pascal Nicole; Yossan-Var Tan; Emilie Ceraudo; Marc Laburthe
The VPAC1 receptor: structure and function of a class B GPCR prototype.
Frontiers in endocrinology 2012;3():139.
2012: Alain Couvineau; Marc Laburthe
The family B1 GPCR: structural aspects and interaction with accessory proteins.
Current drug targets 2012;13(1):103-15.
2011: Sandrine Passemard; Patrick Robberecht; Alain Verloes; Catherine Verney; Guilan Vodjdani; Vincent El Ghouzzi; Pierre Gressens; Marc Laburthe; Adrien Lacaud; Sophie Lebon; Shyamala Mani; Jeannette Nardelli; Hala Nasser; Vincent Lelièvre
VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.
The Journal of clinical investigation 2011;121(8):3071-87.
2011: Thierry Voisin; Aadil El Firar; Magali Fasseu; Christiane Rouyer-Fessard; Véronique Descatoire; Francine Walker; Valérie Paradis; Pierre Bedossa; Dominique Henin; Thérèse Lehy; Marc Laburthe
Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis.
Cancer research 2011;71(9):3341-51.
2010: Alain Couvineau; Emilie Ceraudo; Yossan-Var Tan; Marc Laburthe
VPAC1 receptor binding site: contribution of photoaffinity labeling approach.
Neuropeptides 2010;44(2):127-32.
2010: Magali Fasseu; Xavier Tréton; Cécile Guichard; Eric Pedruzzi; Dominique Cazals-Hatem; Christophe Richard; Thomas Aparicio; Fanny Daniel; Jean-Claude Soulé; Richard Moreau; Yoram Bouhnik; Marc Laburthe; André Groyer; Eric Ogier-Denis
Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.
PloS one 2010;5(10):.
2009: Aadil El Firar; Thierry Voisin; Christiane Rouyer-Fessard; Mariano A Ostuni; Alain Couvineau; Marc Laburthe
Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009;23(12):4069-80.
2009: Steve Bourgault; David Vaudry; Isabelle Ségalas-Milazzo; Laure Guilhaudis; Alain Couvineau; Marc Laburthe; Hubert Vaudry; Alain Fournier
Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.
Journal of medicinal chemistry 2009;52(10):3308-16.
2009: Valérie Gratio; Francine Walker; Thérèse Lehy; Marc Laburthe; Dalila Darmoul
Aberrant expression of proteinase-activated receptor 4 promotes colon cancer cell proliferation through a persistent signaling that involves Src and ErbB-2 kinase.
International journal of cancer. Journal international du cancer 2009;124(7):1517-25.
2008: Emilie Ceraudo; Yossan-Var Tan; Pascal Nicole; Alain Couvineau; Marc Laburthe
The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptor.
Journal of molecular neuroscience : MN 2008;36(1-3):245-8.
2008: Alain Couvineau; Jean-Claude Robert; Tarik Ramdani; Jean-Jacques Lacapère; Christiane Rouyer-Fessard; Marc Laburthe
Production and purification of large quantities of the functional N-terminal ectodomain of human VPAC1 receptor.
Journal of molecular neuroscience : MN 2008;36(1-3):249-53.
2008: Steve Bourgault; David Vaudry; Laure Guilhaudis; Emilie Raoult; Alain Couvineau; Marc Laburthe; Isabelle Ségalas-Milazzo; Hubert Vaudry; Alain Fournier
Biological and structural analysis of truncated analogs of PACAP27.
Journal of molecular neuroscience : MN 2008;36(1-3):260-9.
2008: Nicolas Aubert; David Vaudry; Anthony Falluel-Morel; Arnaud Desfeux; Cecile Fisch; Philippe Ancian; Stéphane De Jouffrey; Jean-François Le Bigot; Alain Couvineau; Marc Laburthe; Alain Fournier; Vincent Laudenbach; Hubert Vaudry; Bruno J Gonzalez
PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: involvement of the mitochondrial apoptotic pathway.
Neurobiology of disease 2008;32(1):66-80.
2008: Jean-Michel Neumann; Alain Couvineau; Samuel Murail; Jean-Jacques Lacapère; Nadège Jamin; Marc Laburthe
Class-B GPCR activation: is ligand helix-capping the key?
Trends in biochemical sciences 2008;33(7):314-9.
2008: Steve Bourgault; David Vaudry; Béatrice Botia; Alain Couvineau; Marc Laburthe; Hubert Vaudry; Alain Fournier
Novel stable PACAP analogs with potent activity towards the PAC1 receptor.
Peptides 2008;29(6):919-32.
2008: Thierry Voisin; Aadil El Firar; Christiane Rouyer-Fessard; Valérie Gratio; Marc Laburthe
A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(6):1993-2002.
2008: Emilie Ceraudo; Samuel Murail; Yossan-Var Tan; Jean-Jacques Lacapère; Jean-Michel Neumann; Alain Couvineau; Marc Laburthe
The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics.
Molecular endocrinology (Baltimore, Md.) 2008;22(1):147-55.
2007: Anne Jarry; Laetitia Dorso; Valérie Gratio; Marie-Elisabeth Forgue-Lafitte; Marc Laburthe; Christian L Laboisse; Dalila Darmoul
PAR-2 activation increases human intestinal mucin secretion through EGFR transactivation.
Biochemical and biophysical research communications 2007;364(3):689-94.
2007: Robert Ducroc; Thierry Voisin; Aadil El Firar; Marc Laburthe
Orexins control intestinal glucose transport by distinct neuronal, endocrine, and direct epithelial pathways.
Diabetes 2007;56(10):2494-500.
2007: Geraldine Favrais; Alain Couvineau; Marc Laburthe; Pierre Gressens; Vincent Lelievre
Involvement of VIP and PACAP in neonatal brain lesions generated by a combined excitotoxic/inflammatory challenge.
Peptides 2007;28(9):1727-37.
2007: Marc Laburthe; Alain Couvineau; Var Tan
Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology.
Peptides 2007;28(9):1631-9.
2007: Eric Ogier-Denis; Magali Fasseu; Alain Vandewalle; Marc Laburthe
[MicroRNAs and intestinal pathophysiology].
Médecine sciences : M/S 2007;23(5):509-14.
2006: Thierry Voisin; Aadil El Firar; Virgile Avondo; Marc Laburthe
Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor.
Endocrinology 2006;147(10):4977-84.
2006: Yossan-Var Tan; Alain Couvineau; Jean-Jacques Lacapere; Marc Laburthe
Characterization of the new photoaffinity probe (Bz2-K24)-VIP.
Annals of the New York Academy of Sciences 2006;1070():575-80.
2006: Colin Debaigt; Annie-Claire Meunier; Stéphanie Goursaud; Alicia Montoni; Nicolas Pineau; Alain Couvineau; Marc Laburthe; Jean-Marc MULLER; Thierry Janet
Expression and GTP sensitivity of peptide histidine isoleucine high-affinity-binding sites in rat.
Annals of the New York Academy of Sciences 2006;1070():215-9.
2006: Alain Couvineau; Yossan-Var Tan; Emilie Ceraudo; Jean-Jacques Lacapère; Samuel Murail; Jean-Michel Neumann; Marc Laburthe
The human VPAC1 receptor: identification of the N-terminal ectodomain as a major VIP-binding site by photoaffinity labeling and 3D modeling.
Annals of the New York Academy of Sciences 2006;1070():205-9.
2006: Emilie Ceraudo; Yossan-Var Tan; Alain Couvineau; Jean-Jacques Lacapere; Marc Laburthe
Spatial approximation between the C-terminus of VIP and the N-terminal ectodomain of the VPAC1 receptor.
Annals of the New York Academy of Sciences 2006;1070():180-4.
2006: Yossan-Var Tan; Alain Couvineau; Samuel Murail; Emilie Ceraudo; Jean-Michel Neumann; Jean-Jacques Lacapère; Marc Laburthe
Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling.
The Journal of biological chemistry 2006;281(18):12792-8.
2004: Alain Couvineau; Christiane Rouyer-Fessard; Marc Laburthe
Presence of a N-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor.
Regulatory peptides 2004;123(1-3):181-5.
2004: Patricia Rouet-Benzineb; Christiane Rouyer-Fessard; Anne Jarry; Virgile Avondo; Cécile Pouzet; Masashi Yanagisawa; Christian L Laboisse; Marc Laburthe; Thierry Voisin
Orexins acting at native OX(1) receptor in colon cancer and neuroblastoma cells or at recombinant OX(1) receptor suppress cell growth by inducing apoptosis.
The Journal of biological chemistry 2004;279(44):45875-86.
2004: Yossan-Var Tan; Alain Couvineau; Marc Laburthe
Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP.
The Journal of biological chemistry 2004;279(37):38889-94.
2004: Dalila Darmoul; Valérie Gratio; Hélène Devaud; Franck Peiretti; Marc Laburthe
Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
Molecular cancer research : MCR 2004;2(9):514-22.
2004: Dalila Darmoul; Valérie Gratio; Hélène Devaud; Marc Laburthe
Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation.
The Journal of biological chemistry 2004;279(20):20927-34.
2003: Jean-Claude Marie; Christiane Rouyer-Fessard; Alain Couvineau; Pascal Nicole; Hélène Devaud; Jamel El Benna; Marc Laburthe
Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
Molecular pharmacology 2003;64(6):1565-74.
2003: Yossan-Var Tan; Alain Couvineau; Jean Van Rampelbergh; Marc Laburthe
Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor.
The Journal of biological chemistry 2003;278(38):36531-6.
2003: Alain Couvineau; Jean-Jacques Lacapere; Yossan-Var Tan; Christiane Rouyer-Fessard; Pascal Nicole; Marc Laburthe
Identification of cytoplasmic domains of hVPAC1 receptor required for activation of adenylyl cyclase. Crucial role of two charged amino acids strictly conserved in class II G protein-coupled receptors.
The Journal of biological chemistry 2003;278(27):24759-66.
2003: Dalila Darmoul; Valérie Gratio; Hélène Devaud; Thérèse Lehy; Marc Laburthe
Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.
The American journal of pathology 2003;162(5):1503-13.
2003: Arthur Christopoulos; George Christopoulos; Maria Morfis; Madhara Udawela; Marc Laburthe; Alain Couvineau; Kenji Kuwasako; Nanda Tilakaratne; Patrick M Sexton
Novel receptor partners and function of receptor activity-modifying proteins.
The Journal of biological chemistry 2003;278(5):3293-7.
2003: Thierry Voisin; Patricia Rouet-Benzineb; N Reuter; Marc Laburthe
Orexins and their receptors: structural aspects and role in peripheral tissues.
Cellular and molecular life sciences : CMLS 2003;60(1):72-87.
2002: Marc Laburthe; Alain Couvineau
Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.
Regulatory peptides 2002;108(2-3):165-73.
2002: Kai Du; Alain Couvineau; Christiane Rouyer-Fessard; Pascal Nicole; Marc Laburthe
Human VPAC1 receptor selectivity filter. Identification of a critical domain for restricting secretin binding.
The Journal of biological chemistry 2002;277(40):37016-22.
2002: Robert Ducroc; Claire Bontemps; Katia Marazova; Hélène Devaud; Dalila Darmoul; Marc Laburthe
Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cells: evidence for new autocrine loop.
Life sciences 2002;70(12):1359-67.
2002: Marc Laburthe; Alain Couvineau; Jean-Claude Marie
VPAC receptors for VIP and PACAP.
Receptors & channels 2002;8(3-4):137-53.
2001: Marion Buyse; F Berlioz; Sandra Guilmeau; Annick Tsocas; Thierry Voisin; G Péranzi; Didier Merlin; Marc Laburthe; MJ Lewin; Claude Rozé; André Bado
PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine.
The Journal of clinical investigation 2001;108(10):1483-94.
2001: Dalila Darmoul; Jean-Claude Marie; Hélène Devaud; Valérie Gratio; Marc Laburthe
Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2.
British journal of cancer 2001;85(5):772-9.
2001: M Goumain; Thierry Voisin; AM Lorinet; Robert Ducroc; Annick Tsocas; Claude Rozé; Patricia Rouet-Benzineb; Herbert Herzog; Ambikaipakan Balasubramaniam; Marc Laburthe
The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning.
Molecular pharmacology 2001;60(1):124-34.
2001: laurence lins; Alain Couvineau; Christiane Rouyer-Fessard; Pascal Nicole; JJ Maoret; M Benhamed; R Brasseur; Annick Thomas; Marc Laburthe
The human VPAC1 receptor: three-dimensional model and mutagenesis of the N-terminal domain.
The Journal of biological chemistry 2001;276(13):10153-60.
2000: Pascal Nicole; JJ Maoret; Alain Couvineau; F A Momany; Marc Laburthe
Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding.
Biochemical and biophysical research communications 2000;276(2):654-9.
2000: Ambikaipakan Balasubramaniam; Zhiyong Tao; Weixu Zhai; M Stein; Sulaiman Sheriff; William T Chance; J E Fischer; P E Eden; J E Taylor; Carson D Liu; David W McFadden; Thierry Voisin; C Roze; Marc Laburthe
Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine.
Journal of medicinal chemistry 2000;43(18):3420-7.
2000: Pascal Nicole; laurence lins; Christiane Rouyer-Fessard; C Drouot; Pierre Fulcrand; Annick Thomas; Alain Couvineau; Jean Martinez; R Brasseur; Marc Laburthe
Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide.
The Journal of biological chemistry 2000;275(31):24003-12.
2000: F Berlioz; JJ Maoret; Hervé Paris; Marc Laburthe; Robert Farinotti; Claude Rozé
alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line.
The Journal of pharmacology and experimental therapeutics 2000;294(2):466-72.
2000: Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; I Carrero; Marc Laburthe
The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.
The Biochemical journal 2000;347 Pt 3():623-32.
2000: Thierry Voisin; M Goumain; AM Lorinet; JJ Maoret; Marc Laburthe
Functional and molecular properties of the human recombinant Y4 receptor: resistance to agonist-promoted desensitization.
The Journal of pharmacology and experimental therapeutics 2000;292(2):638-46.
2000: Pascal Nicole; Christiane Rouyer-Fessard; Alain Couvineau; C Drouot; Pierre Fulcrand; Jean Martinez; Marc Laburthe
Alanine scanning of VIP. Structure-function relationship for binding to human recombinant VPAC1 receptor.
Annals of the New York Academy of Sciences 2000;921():352-6.
2000: M Goumain; Thierry Voisin; Marc Laburthe
Y receptors characterized by RT-PCR. Distribution in rat intestine.
Methods in molecular biology (Clifton, N.J.) 2000;153():209-17.
2000: Thierry Voisin; AM Lorinet; M Goumain; Marc Laburthe
A G alpha i RNA-antisense expression strategy to investigate coupling of peptide YY/neuropeptide Y receptor to G alpha i.
Methods in molecular biology (Clifton, N.J.) 2000;153():115-28.
1999: JJ Maoret; Y Anini; Christiane Rouyer-Fessard; D Gully; Marc Laburthe
Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice.
International journal of cancer. Journal international du cancer 1999;80(3):448-54.
1999: P Gaudin; Alain Couvineau; Christiane Rouyer-Fessard; JJ Maoret; Marc Laburthe
The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343.
Biochemical and biophysical research communications 1999;254(1):15-20.
1998: Kai Du; Pascal Nicole; Alain Couvineau; Marc Laburthe
Construction of chimeras between human VIP1 and secretin receptors: identification of receptor domains involved in selectivity towards VIP, secretin, and PACAP.
Annals of the New York Academy of Sciences 1998;865():386-9.
1998: P Gaudin; Christiane Rouyer-Fessard; Alain Couvineau; JJ Maoret; Marc Laburthe
Constitutive activation of the human VIP1 receptor.
Annals of the New York Academy of Sciences 1998;865():382-5.
1998: Pascal Nicole; Kai Du; Alain Couvineau; Marc Laburthe
Site-directed mutagenesis of human VIP1 versus VIP2 receptors.
Annals of the New York Academy of Sciences 1998;865():378-81.
1998: Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; I Carrero; Marc Laburthe
Cloning and functional characterization of the human VIP1/PACAP receptor promoter.
Annals of the New York Academy of Sciences 1998;865():59-63.
1998: M Goumain; Thierry Voisin; AM Lorinet; Ambikaipakan Balasubramaniam; Marc Laburthe
Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 receptor.
European journal of pharmacology 1998;362(2-3):245-9.
1998: M Goumain; Thierry Voisin; AM Lorinet; Marc Laburthe
Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Biochemical and biophysical research communications 1998;247(1):52-6.
1998: C Rovère; P Barbero; JJ Maoret; Marc Laburthe; Patrick Kitabgi
Pro-neurotensin/neuromedin N expression and processing in human colon cancer cell lines.
Biochemical and biophysical research communications 1998;246(1):155-9.
1998: P Gaudin; JJ Maoret; Alain Couvineau; Christiane Rouyer-Fessard; Marc Laburthe
Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors.
The Journal of biological chemistry 1998;273(9):4990-6.
1998: Pascal Nicole; Kai Du; Alain Couvineau; Marc Laburthe
Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.
The Journal of pharmacology and experimental therapeutics 1998;284(2):744-50.
1997: Kai Du; Pascal Nicole; Alain Couvineau; Marc Laburthe
Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.
Biochemical and biophysical research communications 1997;230(2):289-92.
1997: A Souli; J Chariot; Thierry Voisin; Olivier Presset; Annick Tsocas; Ambikaipakan Balasubramaniam; Marc Laburthe; Claude Rozé
Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo.
Peptides 1997;18(4):551-7.
1997: Pascal Nicole; Kai Du; Alain Couvineau; Marc Laburthe
[Directed mutagenesis of human recombinant receptors of vasoactive intestinal peptide of VIP1 and VIP2 type. Difference in structure-activity relationship].
Gastroentérologie clinique et biologique 1997;21(5):365-9.
1996: P Gaudin; Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; Marc Laburthe
Role of cysteine residues in the N-terminal extracellular domain of the human VIP 1 receptor for ligand binding. A site-directed mutagenesis study.
Annals of the New York Academy of Sciences 1996;805():585-9.
1996: P Gaudin; Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; Marc Laburthe
Establishment of a CHO cell clone stably expressing the recombinant human VIP-1 receptor.
Annals of the New York Academy of Sciences 1996;805():570-3.
1996: Alain Couvineau; C Fabre; P Gaudin; JJ Maoret; Marc Laburthe
Mutagenesis of N-glycosylation sites in the human VIP 1 receptor.
Annals of the New York Academy of Sciences 1996;805():558-62.
1996: Marc Laburthe; Alain Couvineau; P Gaudin; JJ Maoret; Christiane Rouyer-Fessard; Pascal Nicole
Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor.
Annals of the New York Academy of Sciences 1996;805():94-109; discussion 110-1.
1996: Thierry Voisin; AM Lorinet; Marc Laburthe
Partial knockdown of G alpha i2 protein is sufficient to abolish the coupling of PYY receptors to biological response in renal proximal tubule cells.
Biochemical and biophysical research communications 1996;225(1):16-21.
1996: Alain Couvineau; Christiane Rouyer-Fessard; JJ Maoret; P Gaudin; Pascal Nicole; Marc Laburthe
Vasoactive intestinal peptide (VIP)1 receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide.
The Journal of biological chemistry 1996;271(22):12795-800.
1996: P Gaudin; Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; Marc Laburthe
Stable expression of the recombinant human VIP1 receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties.
European journal of pharmacology 1996;302(1-3):207-14.
1996: Alain Couvineau; C Fabre; P Gaudin; JJ Maoret; Marc Laburthe
Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.
Biochemistry 1996;35(6):1745-52.
1996: Thierry Voisin; AM Lorinet; JJ Maoret; Alain Couvineau; Marc Laburthe
G alpha i RNA antisense expression demonstrates the exclusive coupling of peptide YY receptors to G(i)2 proteins in renal proximal tubule cells.
The Journal of biological chemistry 1996;271(1):574-80.
1995: P Gaudin; Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; Marc Laburthe
Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding.
Biochemical and biophysical research communications 1995;211(3):901-8.
1995: Eric Ogier-Denis; Alain Couvineau; JJ Maoret; J J Houri; Chantal Bauvy; Daniela De Stefanis; Ciro Isidoro; Marc Laburthe; Patrice Codogno
A heterotrimeric Gi3-protein controls autophagic sequestration in the human colon cancer cell line HT-29.
The Journal of biological chemistry 1995;270(1):13-6.
1995: Alain Couvineau; P Gaudin; JJ Maoret; Christiane Rouyer-Fessard; Pascal Nicole; Marc Laburthe
Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP.
Biochemical and biophysical research communications 1995;206(1):246-52.
1994: N Rodriguez-Henche; Luis G Guijarro; Alain Couvineau; Isabel Carrero; Eduardo Arilla; Marc Laburthe; Juan Prieto
G proteins in rat liver proliferation during cholestasis.
Hepatology (Baltimore, Md.) 1994;20(4 Pt 1):1041-7.
1994: D Darmoul; Thierry Voisin; Alain Couvineau; Christiane Rouyer-Fessard; R Salomon; Y Wang; Dallas M Swallow; Marc Laburthe
Regional expression of epithelial dipeptidyl peptidase IV in the human intestines.
Biochemical and biophysical research communications 1994;203(2):1224-9.
1994: JJ Maoret; D Pospaï; Christiane Rouyer-Fessard; Alain Couvineau; Christian L Laboisse; Thierry Voisin; Marc Laburthe
Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonic epithelium: binding studies and RT-PCR experiments.
Biochemical and biophysical research communications 1994;203(1):465-71.
1994: Alain Couvineau; Christiane Rouyer-Fessard; D Darmoul; JJ Maoret; Isabel Carrero; Eric Ogier-Denis; Marc Laburthe
Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains.
Biochemical and biophysical research communications 1994;200(2):769-76.
1994: I Castan; Philippe Valet; N Quideau; Thierry Voisin; L Ambid; Marc Laburthe; Max Lafontan; Christian Carpéné
Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes.
The American journal of physiology 1994;266(4 Pt 2):R1141-7.
1993: I Castan; Philippe Valet; Dominique Larrouy; Thierry Voisin; A Remaury; Danièle Daviaud; Marc Laburthe; Max Lafontan
Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the alpha 2-adrenergic system.
The American journal of physiology 1993;265(1 Pt 1):E74-80.
1993: C Fabre; Assou El-Battari; Y Karamanos; Alain Couvineau; R Salomon; Marc Laburthe; Jacques Marvaldi; J Pichon; José Luis
Glycosylation of VIP receptors: a molecular basis for receptor heterogeneity.
Peptides 1993;14(3):483-9.
1993: R Salomon; Alain Couvineau; Christiane Rouyer-Fessard; Thierry Voisin; D Lavallée; A Blais; D Darmoul; Marc Laburthe
Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
The American journal of physiology 1993;264(2 Pt 1):E294-300.
1992: I Castan; Philippe Valet; Thierry Voisin; N Quideau; Marc Laburthe; Max Lafontan
Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
Endocrinology 1992;131(4):1970-6.
1992: Luis G Guijarro; Alain Couvineau; M S Rodriguez-Pena; María G Juarranz; N Rodriguez-Henche; Eduardo Arilla; Marc Laburthe; Juan Prieto
Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy.
The Biochemical journal 1992;285 ( Pt 2)():515-20.
1992: Alain Couvineau; D Darmoul; A Blais; Christiane Rouyer-Fessard; Danièle Daviaud; Thierry Voisin; Hervé Paris; Bruno Rouot; Marc Laburthe
Gs and Gi protein subunits during cell differentiation in intestinal crypt-villus axis: regulation at the mRNA level.
The American journal of physiology 1992;262(6 Pt 1):C1478-84.
1992: C Augeron; Thierry Voisin; JJ Maoret; B Berthon; Marc Laburthe; Christian L Laboisse
Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptors.
The American journal of physiology 1992;262(3 Pt 1):G470-6.
1991: D Darmoul; Christiane Rouyer-Fessard; A Blais; Thierry Voisin; Catherine Sapin; L Baricault; C Cibert; G Geraud; Alain Couvineau; Marc Laburthe
Dipeptidyl peptidase IV expression in rat jejunal crypt-villus axis is controlled at mRNA level.
The American journal of physiology 1991;261(5 Pt 1):G763-9.
1991: Thierry Voisin; Alain Couvineau; Christiane Rouyer-Fessard; Marc Laburthe
Solubilization and hydrodynamic properties of active peptide YY receptor from rat jejunal crypts. Characterization as a Mr 44,000 glycoprotein.
The Journal of biological chemistry 1991;266(17):10762-7.
1990: Hervé Paris; Thierry Voisin; A Remaury; Christiane Rouyer-Fessard; Danièle Daviaud; Dominique Langin; Marc Laburthe
Alpha-2 adrenoceptor in rat jejunum epithelial cells: characterization with [3H]RX821002 and distribution along the villus-crypt axis.
The Journal of pharmacology and experimental therapeutics 1990;254(3):888-93.
1990: Alain Couvineau; Thierry Voisin; Luis G Guijarro; Marc Laburthe
Purification of vasoactive intestinal peptide receptor from porcine liver by a newly designed one-step affinity chromatography.
The Journal of biological chemistry 1990;265(22):13386-90.
1989: Christiane Rouyer-Fessard; C Augeron; E Grasset; JJ Maoret; Christian L Laboisse; Marc Laburthe
VIP receptors and control of short circuit current in the human intestinal clonal cell line Cl.19A.
Experientia 1989;45(11-12):1102-5.
1989: Marc Laburthe; C Augeron; Christiane Rouyer-Fessard; I Roumagnac; JJ Maoret; E Grasset; Christian L Laboisse
Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E.
The American journal of physiology 1989;256(3 Pt 1):G443-50.
1989: Christiane Rouyer-Fessard; Alain Couvineau; Thierry Voisin; Marc Laburthe
Ac-Tyr1hGRF discriminates between VIP receptors from rat liver and intestinal epithelium.
Life sciences 1989;45(9):829-33.